These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7656625)

  • 21. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease.
    Papi A; Romagnoli M; Baraldo S; Braccioni F; Guzzinati I; Saetta M; Ciaccia A; Fabbri LM
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1773-7. PubMed ID: 11069811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchodilator responsiveness in patients with chronic heart failure.
    Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
    Heart Lung; 2013; 42(3):208-14. PubMed ID: 23273658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and treatment of chronic airways obstruction in adults over the age of 45.
    Renwick DS; Connolly MJ
    Thorax; 1996 Feb; 51(2):164-8. PubMed ID: 8711649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study.
    Singh D; Zhu CQ; Sharma S; Church A; Kalberg CJ
    Pulm Pharmacol Ther; 2015 Apr; 31():85-91. PubMed ID: 25197005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT and functional respiratory tests. Evaluation of efficacy of bronchodilator therapy in chronic obstructive pulmonary disease (COPD).
    Costantini AM; Sallustio G; Misciasci T; Corbo GM; Valente S; Pirronti T; Marano P
    Radiol Med; 2004; 108(1-2):17-27. PubMed ID: 15269687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life.
    Guyatt GH; Townsend M; Pugsley SO; Keller JL; Short HD; Taylor DW; Newhouse MT
    Am Rev Respir Dis; 1987 May; 135(5):1069-74. PubMed ID: 3579005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined bronchodilator therapy in the management of chronic obstructive pulmonary disease.
    Friedman M
    Respirology; 1997; 2 Suppl 1():S19-23. PubMed ID: 9400691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
    Pillet O; Manier G; Castaing Y
    Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salmeterol reduces dyspnea and improves lung function in patients with COPD.
    Ramirez-Venegas A; Ward J; Lentine T; Mahler DA
    Chest; 1997 Aug; 112(2):336-40. PubMed ID: 9266866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.
    Hizawa N; Makita H; Nasuhara Y; Betsuyaku T; Itoh Y; Nagai K; Hasegawa M; Nishimura M
    Chest; 2007 Nov; 132(5):1485-92. PubMed ID: 17890463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.
    Walker PP; Calverley PM
    COPD; 2008 Jun; 5(3):147-52. PubMed ID: 18568838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchodilator reversibility in patients with COPD revisited: short-term reproducibility.
    Pascoe S; Wu W; Zhu CQ; Singh D
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2035-40. PubMed ID: 27621609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea.
    Kim SJ; Suk MH; Choi HM; Kimm KC; Jung KH; Lee SY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1393-8. PubMed ID: 17167958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative functional criteria to assess airflow-limitation reversibility in asthma.
    Tavares e Castro A; Matos P; Tavares B; Matos MJ; Segorbe-Luís A
    Rev Port Pneumol (2006); 2015; 21(2):69-75. PubMed ID: 25926369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An evaluation of inhaled bronchodilator therapy in patients hospitalized for non-life-threatening COPD exacerbations.
    Woods JA; Usery JB; Self TH; Finch CK
    South Med J; 2011 Nov; 104(11):742-5. PubMed ID: 22024782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective, comparative trial of standard and breath-actuated nebulizer: efficacy, safety, and satisfaction.
    Arunthari V; Bruinsma RS; Lee AS; Johnson MM
    Respir Care; 2012 Aug; 57(8):1242-7. PubMed ID: 22348319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute bronchodilator responsiveness in bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation.
    Barisione G; Bacigalupo A; Crimi E; Brusasco V
    Chest; 2011 Mar; 139(3):633-639. PubMed ID: 20724742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of bronchodilators: searching for objective criteria].
    Aguilaniu B
    Rev Pneumol Clin; 2003 Apr; 59(2 Pt 2):S11-5. PubMed ID: 12966780
    [No Abstract]   [Full Text] [Related]  

  • 39. Which patients are prescribed inhaled anti-asthma drugs?
    Roberts SJ; Bateman DN
    Thorax; 1994 Nov; 49(11):1090-5. PubMed ID: 7831622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of salmeterol in the treatment of smokers with chronic obstructive lung disease].
    Ulrik CS
    Ugeskr Laeger; 1996 Jun; 158(25):3604-7. PubMed ID: 8693619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.